CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- 4 Open-market sale Chief Innovation Officer sold 19,517 shares at $31.21 ($609,087)
- 4 Open-market sale Chief Marketing Officer sold 8,156 shares at $31.21 ($254,532)
- 4 Open-market sale EVP & General Counsel sold 9,278 shares at $31.21 ($289,548)
- 4 Open-market sale Director sold 21,399 shares at $29.61 ($633,710)
- 4 Open-market sale Director sold 45,379 shares at an average $30.64 ($1,390,393)
- 4 Open-market sale CFO sold 14,387 shares at an average $31.56 ($454,005)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award EVP & General Counsel acquired 22,500 shares (grant or award)
- 4 Grant or award Chief Innovation Officer acquired 40,000 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 22,500 shares (grant or award)
- 8-K Event Executive or director change
- 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 22,818 shares at an average $24.01 ($547,889)
Page 5 of 69 · 1,369 filings